Pharma R&D & Clinical Services · Indirect
Monitoring · monthlyProcurement Category Intelligence
Antibody Drug Conjugate Manufacturing
Overview
Market size
$23.5B
global, USD
CAGR
18.5%
base to forecast
Buyer power
-2.4
supplier-favoured
Suppliers
8
tracked players
Signals
8
2 high severity
Market outlook
2031$54.9B
What changed
Demand by region
North America demand45%
Europe demand30%
Asia Pacific demand20%
Rest of world demand5%
share of global demandtotal 100%
Cost drivers
High-potency active pharmaceutical ingredients and payloads35%
Upstream monoclonal antibody biomanufacturing and cell-line development25%
Specialized containment, safety equipment, and cleanroom facilities15%
Chemical linkers and conjugation process technologies15%
Quality control, regulatory compliance, and sterile fill-finish operations10%
share of delivered cost (analyst estimate)